Oral administration of cytosolic PLA2 inhibitor arachidonyl trifluoromethyl ketone ameliorates cauda equina compression injury in rats

Cytosolic phospholipase A2protein as a novel therapeutic target for spinal cord injury

(2014) Nai-Kui Liu et al.   ANNALS OF NEUROLOGY

LPA receptor signaling: pharmacology, physiology, and pathophysiology

(2014) Yun C. Yung et al.   JOURNAL OF LIPID RESEARCH

The Relationship Between the Duration of Acute Cauda Equina Compression and Functional Outcomes in a Rat Model

(2014) R. Andrew Glennie et al.   SPINE

Lysoglycerophospholipids in chronic inflammatory disorders: The PLA2/LPC and ATX/LPA axes

(2012) Ioanna Sevastou et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Inhibition of cytosolic phospholipase A2 alpha protects against focal ischemic brain damage in mice

(2012) Jian Zhang et al.   BRAIN RESEARCH

Role of phospholipase A2s and lipid mediators in secondary damage after spinal cord injury

(2012) Samuel David et al.   CELL AND TISSUE RESEARCH

Simvastatin Ameliorates Cauda Equina Compression Injury in a Rat Model of Lumbar Spinal Stenosis

(2012) Anandakumar Shunmugavel et al.   Journal of Neuroimmune Pharmacology

Leukotrienes in Nociceptive Pathway and Neuropathic/Inflammatory Pain

(2011) Koichi Noguchi et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Lumbar spinal stenosis: a brief review of the nonsurgical management

(2010) De Q. H. Tran et al.   Canadian Journal of Anesthesia-Journal canadien d anesthesie

Cytosolic phospholipase A2 as a mediator of disease pathogenesis

(2010) Amanda Linkous et al.   CELLULAR MICROBIOLOGY

Animal models of neuropathic pain

(2010) Amteshwar Singh Jaggi et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

A novel role of prostaglandin E2 in neuropathic pain

(2010) Shunji Kunori et al.   GLIA

Evidence for De Novo Synthesis of Lysophosphatidic Acid in the Spinal Cord through Phospholipase A2 and Autotaxin in Nerve Injury-Induced Neuropathic Pain

(2010) L. Ma et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Autotaxin and Lysophosphatidic Acid1 receptor-Mediated Demyelination of Dorsal Root Fibers by Sciatic Nerve Injury and Intrathecal Lysophosphatidylcholine

(2010) Jun Nagai et al.   Molecular Pain

Neuropathische Schmerzsyndrome und Neuroplastizität in der funktionellen Bildgebung

(2010) C. Maihöfner et al.   SCHMERZ

Phospholipase A2inhibitors as potential therapeutic agents for the treatment of inflammatory diseases

(2009) Victoria Magrioti et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Administration of S-nitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact

(2009) Mushfiquddin Khan et al.   Journal of Neuroinflammation

Arachidonyl Trifluoromethyl Ketone Is Neuroprotective after Spinal Cord Injury

(2009) Wenlong Huang et al.   JOURNAL OF NEUROTRAUMA

Lumbar spinal stenosis: syndrome, diagnostics and treatment

(2009) Eberhard Siebert et al.   Nature Reviews Neurology

Compensatory Neovascularization After Cauda Equina Compression in Rats

(2009) Tadashi Yonetake et al.   SPINE

Lipid Mediators in Health and Disease: Enzymes and Receptors as Therapeutic Targets for the Regulation of Immunity and Inflammation

(2008) Takao Shimizu   Annual Review of Pharmacology and Toxicology

Inhibition of cyclooxygenases 1 and 2 by the phospholipase-blocker, arachidonyl trifluoromethyl ketone

(2008) H J Leis et al.   BRITISH JOURNAL OF PHARMACOLOGY

Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease

(2008) Rene O Sanchez-Mejia et al.   NATURE NEUROSCIENCE

Pharmacological assessments of nitric oxide synthase isoforms and downstream diversity of NO signaling in the maintenance of thermal and mechanical hypersensitivity after peripheral nerve injury in mice

(2008) Mitsuo Tanabe et al.   NEUROPHARMACOLOGY

Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid

(2008) M. Inoue et al.   NEUROSCIENCE

Spinal nerve ligation–induced activation of nuclear factor kappaB is facilitated by prostaglandins in the affected spinal cord and is a critical step in the development of mechanical allodynia

(2008) D.D. O'Rielly et al.   NEUROSCIENCE